Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway.
机构:[1]Department of Gynaecology, Hubei Maternity and Child Health Hospital, Wuhan, China[2]Department of Obstetrics and Gynaecology, Beijing Hospital, Beijing, China[3]Department of Obstetrics and Gynaecology, Haidian Woman’s and Children’s Hospital, Beijing, China首都医科大学附属北京儿童医院[4]Department of Obstetrics and Gynaecology, Dongguan Hospital of Traditional Chinese Medicine, Dongguan Guangdong, China
第一作者机构:[1]Department of Gynaecology, Hubei Maternity and Child Health Hospital, Wuhan, China
通讯作者:
通讯机构:[2]Department of Obstetrics and Gynaecology, Beijing Hospital, Beijing, China[*1]Department of Obstetrics and Gynaecology, Beijing Hospital, 1 Dongdan Dahua Road, 100730 Beijing, China
推荐引用方式(GB/T 7714):
Yan Wang,Liang-Yan Shi,Wei-Hong Qi,et al.Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway.[J].Archives of medical science : AMS.2020,16(2):428-435.doi:10.5114/aoms.2017.71420.
APA:
Yan Wang,Liang-Yan Shi,Wei-Hong Qi,Jing Yang&Yue Qi.(2020).Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway..Archives of medical science : AMS,16,(2)
MLA:
Yan Wang,et al."Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway.".Archives of medical science : AMS 16..2(2020):428-435